Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 233

Similar articles for PubMed (Select 20650871)


Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease.

Tye-Din JA, Stewart JA, Dromey JA, Beissbarth T, van Heel DA, Tatham A, Henderson K, Mannering SI, Gianfrani C, Jewell DP, Hill AV, McCluskey J, Rossjohn J, Anderson RP.

Sci Transl Med. 2010 Jul 21;2(41):41ra51. doi: 10.1126/scitranslmed.3001012.


A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.

Dørum S, Qiao SW, Sollid LM, Fleckenstein B.

J Proteome Res. 2009 Apr;8(4):1748-55. doi: 10.1021/pr800960n.


The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.

Dørum S, Arntzen MØ, Qiao SW, Holm A, Koehler CJ, Thiede B, Sollid LM, Fleckenstein B.

PLoS One. 2010 Nov 19;5(11):e14056. doi: 10.1371/journal.pone.0014056.


T cells in peripheral blood after gluten challenge in coeliac disease.

Anderson RP, van Heel DA, Tye-Din JA, Barnardo M, Salio M, Jewell DP, Hill AV.

Gut. 2005 Sep;54(9):1217-23.


Sensitive detection of cereal fractions that are toxic to celiac disease patients by using monoclonal antibodies to a main immunogenic wheat peptide.

Morón B, Cebolla A, Manyani H, Alvarez-Maqueda M, Megías M, Thomas Mdel C, López MC, Sousa C.

Am J Clin Nutr. 2008 Feb;87(2):405-14.


Characterization of cereal toxicity for celiac disease patients based on protein homology in grains.

Vader LW, Stepniak DT, Bunnik EM, Kooy YM, de Haan W, Drijfhout JW, Van Veelen PA, Koning F.

Gastroenterology. 2003 Oct;125(4):1105-13.


Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.

Camarca A, Anderson RP, Mamone G, Fierro O, Facchiano A, Costantini S, Zanzi D, Sidney J, Auricchio S, Sette A, Troncone R, Gianfrani C.

J Immunol. 2009 Apr 1;182(7):4158-66. doi: 10.4049/jimmunol.0803181.


Dissecting the T-cell response to hordeins in coeliac disease can develop barley with reduced immunotoxicity.

Tanner GJ, Howitt CA, Forrester RI, Campbell PM, Tye-Din JA, Anderson RP.

Aliment Pharmacol Ther. 2010 Nov;32(9):1184-91. doi: 10.1111/j.1365-2036.2010.04452.x. Epub 2010 Sep 15.


Repertoire of gluten peptides active in celiac disease patients: perspectives for translational therapeutic applications.

Camarca A, Del Mastro A, Gianfrani C.

Endocr Metab Immune Disord Drug Targets. 2012 Jun;12(2):207-19. Review.


Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.

de Kauwe AL, Chen Z, Anderson RP, Keech CL, Price JD, Wijburg O, Jackson DC, Ladhams J, Allison J, McCluskey J.

J Immunol. 2009 Jun 15;182(12):7440-50. doi: 10.4049/jimmunol.0900233.


Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.

Moustakas AK, van de Wal Y, Routsias J, Kooy YM, van Veelen P, Drijfhout JW, Koning F, Papadopoulos GK.

Int Immunol. 2000 Aug;12(8):1157-66.


Effective shutdown in the expression of celiac disease-related wheat gliadin T-cell epitopes by RNA interference.

Gil-Humanes J, Pistón F, Tollefsen S, Sollid LM, Barro F.

Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):17023-8. doi: 10.1073/pnas.1007773107. Epub 2010 Sep 9.


The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides.

Vader W, Kooy Y, Van Veelen P, De Ru A, Harris D, Benckhuijsen W, Peña S, Mearin L, Drijfhout JW, Koning F.

Gastroenterology. 2002 Jun;122(7):1729-37.


Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease.

Molberg O, Uhlen AK, Jensen T, Flaete NS, Fleckenstein B, Arentz-Hansen H, Raki M, Lundin KE, Sollid LM.

Gastroenterology. 2005 Feb;128(2):393-401.


Fine specificity of monoclonal antibodies against celiac disease-inducing peptides in the gluteome.

Mitea C, Kooy-Winkelaar Y, van Veelen P, de Ru A, Drijfhout JW, Koning F, Dekking L.

Am J Clin Nutr. 2008 Oct;88(4):1057-66.


Antagonist peptides of the gliadin T-cell stimulatory sequences: a therapeutic strategy for celiac disease.

Silano M, Vincentini O, Iapello A, Mancini E, De Vincenzi M.

J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 2:S191-2. doi: 10.1097/MCG.0b013e31817df76a.


Immunogenic peptides can be detected in whole gluten by transamidating highly susceptible glutamine residues: implication in the search for gluten-free cereals.

Mamone G, Camarca A, Fierro O, Sidney J, Mazzarella G, Addeo F, Auricchio S, Troncone R, Sette A, Gianfrani C.

J Agric Food Chem. 2013 Jan 23;61(3):747-54. doi: 10.1021/jf3040435. Epub 2013 Jan 11.


Short wheat challenge is a reproducible in-vivo assay to detect immune response to gluten.

Camarca A, Radano G, Di Mase R, Terrone G, Maurano F, Auricchio S, Troncone R, Greco L, Gianfrani C.

Clin Exp Immunol. 2012 Aug;169(2):129-36. doi: 10.1111/j.1365-2249.2012.04597.x.


Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.

Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, Thorsby E, Sollid LM.

J Exp Med. 1993 Jul 1;178(1):187-96.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk